Novartis AG
Polyomavirus neutralizing antibodies
Last updated:
Abstract:
The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
Status:
Grant
Type:
Utility
Filling date:
18 Oct 2019
Issue date:
2 Nov 2021